Assenagon Asset Management S.A. Bolt Biotherapeutics, Inc. Transaction History
Assenagon Asset Management S.A.
- $47.8 Billion
- Q3 2024
A detailed history of Assenagon Asset Management S.A. transactions in Bolt Biotherapeutics, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 20,785 shares of BOLT stock, worth $10,808. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,785
Previous 34,488
39.73%
Holding current value
$10,808
Previous $25,000
48.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BOLT
# of Institutions
33Shares Held
19.1MCall Options Held
0Put Options Held
0-
Tang Capital Management LLC San Diego, CA3.81MShares$1.98 Million0.21% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.52MShares$1.83 Million0.33% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.75MShares$1.43 Million0.17% of portfolio
-
Pivotal Bio Venture Partners Investment Advisor LLC San Francisco, CA1.89MShares$983,5620.97% of portfolio
-
Nan Fung Group Holdings LTD Central, K31.17MShares$606,8150.74% of portfolio
About Bolt Biotherapeutics, Inc.
- Ticker BOLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,641,500
- Market Cap $19.6M
- Description
- Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...